Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION Cause Upper respiratory tract infection? 509 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 509 reports of Upper respiratory tract infection have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 1.4% of all adverse event reports for BUPROPION.

509
Reports of Upper respiratory tract infection with BUPROPION
1.4%
of all BUPROPION reports
117
Deaths
17
Hospitalizations

How Dangerous Is Upper respiratory tract infection From BUPROPION?

Of the 509 reports, 117 (23.0%) resulted in death, 17 (3.3%) required hospitalization, and 12 (2.4%) were considered life-threatening.

Is Upper respiratory tract infection Listed in the Official Label?

Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for BUPROPION.

What Other Side Effects Does BUPROPION Cause?

Completed suicide (5,095) Drug ineffective (3,991) Toxicity to various agents (3,837) Depression (2,486) Overdose (2,357) Headache (2,323) Anxiety (2,145) Intentional overdose (2,103) Drug hypersensitivity (1,967) Seizure (1,894)

What Other Drugs Cause Upper respiratory tract infection?

ADALIMUMAB (3,306) ETANERCEPT (2,948) TOFACITINIB (1,805) RITUXIMAB (1,713) ABATACEPT (1,623) METHOTREXATE (1,576) TOCILIZUMAB (1,455) APREMILAST (1,437) PREDNISONE (1,354) SECUKINUMAB (1,339)

Which BUPROPION Alternatives Have Lower Upper respiratory tract infection Risk?

BUPROPION vs BUPROPION HYDROBROMIDE BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION vs BUPROPION\NALTREXONE BUPROPION vs BUROSUMAB BUPROPION vs BUROSUMAB-TWZA

Related Pages

BUPROPION Full Profile All Upper respiratory tract infection Reports All Drugs Causing Upper respiratory tract infection BUPROPION Demographics